Press release: "Antidote Technologies named a top innovator in new book for pharma industry"
Tampa, Florida (February 8, 2021) – Buoyed by the need to rapidly identify, trial and commercialize vaccines and therapeutics to fight the global COVID-19 pandemic, the Pharma Services industry’s ability to innovate was amplified to new heights in 2020. Agility, speed, and leveraging new IoT technologies were just some of the themes played out as companies raced to provide solutions. In this hyper-charged environment, Crosstree, a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within the Pharma Services, Diagnostics and Tools, and Digital Health subsectors, is publishing Innovations in Pharmaceutical Development™, a must-have guide to 55 of the most disruptive Pharma Services companies and thought leaders in the world.
At nearly 100 pages, the publication, which is available in both eBook and hardcover formats, serves as a comprehensive guide to the thought leaders, companies, technologies, organizations, leading media platforms and influencers from around the world that are propelling innovation forward. Crosstree’s Innovations in Pharmaceutical Development™ is available for download here for $100 and hard copies can be ordered online for $125 here. An Executive Summary of the book’s content is available here.
Crosstree Co-founder and Managing Director Shane Senior served as one of the publication’s strategists and editorial directors. “Our goal with Innovations in Pharmaceutical Development™ is to connect the world’s best innovations and companies with enablers—customers, investors, analysts, media and other influencers—within the pharmaceutical services industry,” Senior explains. “By no means is this book meant to be exhaustive; our intent is showcase those that rose to the top during a methodically researched and vetted review process.”
He adds, “We believe this publication is one people will turn to again and again for the insights and introductions to people, companies, and technology changing the world.”
Among the companies profiled are Antidote Technologies of New York, NY and London, England, a digital patient engagement company operating in the clinical trial patient recruitment sector that enables faster medical innovation by transforming how patients and researchers connect; InSphero of Zurich, Switzerland, a lab services company whose leading a global effort to make 3D in vitro cell-based assays and organ-on-a-chip technology more human and predictive and therefore safer and more efficacious; and SubjectWell, an Austin, Texas-based clinical services company with a risk-free clinical trial marketplace for patient recruitment, giving patients more choice and access to cutting-edge treatment. Each company review includes deep insights into their tech, leadership, markets, and contact information.
Furthering its value the go-to industry guide in 2021, Innovations in Pharmaceutical Development™ identifies international thought leaders in academia, corporations, and research institutions who share deep insights into market trends and conditions, how emerging technologies are being applied across the industry, and growth opportunities. Given the seismic changes and challenges facing the pharmaceutical industry and the world at large, this publication could not be better timed.
Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. With teams in New York City and Tampa, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. Visit www.crosstreecapital.com.
About Global Village Ventures
Global Village Ventures publish high-quality books and AR videos that showcase industries and lifestyles of cities around the world. Over a period of 12 years, we have successfully duplicated our publishing models in over 60 countries creating an amazing network of publishing partners and friends around the world. The INNOVATE® publishing series is a 300-page in-depth study and AR video series that showcases the people, companies, products, and services that are leading the race within a city or industry's innovation and entrepreneurial ecosystem. A book series with augmented reality video, an online platform, and a global network with a common goal of ensuring the best innovations and innovation enablers connect and succeed.
+1 (813) 992-1470